Trials were performed with four drugs commercialized in Brazil: donepezil, tacrine, galantamine and rivastigmine, utilized in the control of Alzheimer’s disease, to inhibit the activity of acetylcholinesterase. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.